Skip to content
Screener

aTyr Pharma ATYR Price / sales

Price / sales at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
2.4×+0.4×
Merck & Co. logo
Merck & Co.MRK
4.8×+1.6×
United Therapeutics logo
United TherapeuticsUTHR
7.3×+3.0×
Syndax Pharmaceuticals logo
Syndax PharmaceuticalsSNDX
9.5×-14.7×
Stoke Therapeutics, Inc. logo
Stoke Therapeutics, Inc.STOK
60×+58.2×

Other financials

Income statement

See full
Revenue-—
Operating income-$10.9M+46.4%
Net income-$10.3M+47.2%
EPS (diluted)-$0.11+50.0%

Balance sheet

See full
Cash & equivalents$16.2M-6.2%
Total debt$11.8M-10.7%
Total equity$48.8M-34.8%
Total assets$69.8M-31.2%

Cash flow

See full
Operating cash flow-$9.4M+32.7%
CapEx$73.0K+711%
Free cash flow-$9.4M+32.2%

Valuation

See full
Market cap$51.88M-89.6%
Enterprise value$47.54M-90.4%

Profitability

See full
Operating margin-40,856.3%+28,833pp
Net margin-39,009.5%+29,653pp
FCF margin-32,664.7%+4,018pp

Returns & leverage

See full
Return on equity-98.4%+18.0pp
Debt / equity0.2×+0.1×
Current ratio5.1×-0.5×

Where this comes from

Calculated from aTyr Pharma’s reported figures.

market cap/total revenue=403.9×

Based on the most recent quarter.

The source filing: aTyr Pharma’s 10-Q, filed August 7, 2026. Open the filing →

Filed
Aug 7, 2026, 4:07 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001339970-26-000053

FAQ

What is aTyr Pharma's price / sales?
aTyr Pharma (ATYR) reported price / sales of 403.9× in Q4 2025.
How has aTyr Pharma's price / sales changed year-over-year?
aTyr Pharma's price / sales decreased by 68.8% year-over-year, from 1,293.1× to 403.9×.
What does price / sales mean?
Market capitalization at the quarter end divided by trailing-twelve-month revenue. The price the market pays for each dollar of sales.

Ask your AI about aTyr Pharma's price / sales.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude